These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18214341)

  • 1. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
    Chen S; Zhu J; Cheng J
    Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
    Das SK; Das NG
    J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres.
    Sultana Y; Mall S; Maurya DP; Kumar D; Das M
    Pharm Dev Technol; 2009; 14(3):321-31. PubMed ID: 19235550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethyleneimine-treated xanthan beads for prolonged release of diltiazem: in vitro and in vivo evaluation.
    Ray S; Maiti S; Sa B
    Arch Pharm Res; 2010 Apr; 33(4):575-83. PubMed ID: 20422367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of gastric floating sustained-release capsules of Tripterygium wilfordii by using multiparticulate time-controlled release technology].
    Zhang W; Song H; Zhang Q
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2867-71. PubMed ID: 20209947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
    Toti US; Aminabhavi TM
    J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
    Prabakaran D; Singh P; Kanaujia P; Vyas SP
    Int J Pharm; 2003 Jun; 259(1-2):173-9. PubMed ID: 12787645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
    El-Kamel AH; Al-Gohary OM; Hosny EA
    J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.